๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-04

Pomalidomide Treatment in Patients With Kaposi Sarcoma (NCT04577755)

A Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma

๐Ÿ”ต Active, Not Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: National Cancer Institute (NCI)

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells.

Who can join: Review the eligibility criteria below.

Location: UC San Diego Moores Cancer Center โ€” La Jolla, California

Age range: 18 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (15 Sites)

  • UC San Diego Moores Cancer Center โ€” La Jolla, California
  • Miami Cancer Institute โ€” Miami, Florida
  • University of Illinois โ€” Chicago, Illinois
  • Johns Hopkins University/Sidney Kimmel Cancer Center โ€” Baltimore, Maryland
  • Boston Medical Center โ€” Boston, Massachusetts
  • Washington University School of Medicine โ€” St Louis, Missouri
  • Mount Sinai Hospital โ€” New York, New York
  • NYP/Weill Cornell Medical Center โ€” New York, New York
  • Montefiore Medical Center-Einstein Campus โ€” The Bronx, New York
  • Ohio State University Comprehensive Cancer Center โ€” Columbus, Ohio
  • University of Pennsylvania/Abramson Cancer Center โ€” Philadelphia, Pennsylvania
  • Pennsylvania Hospital โ€” Philadelphia, Pennsylvania
  • Thomas Street at Quentin Mease Health Center โ€” Houston, Texas
  • UT MD Anderson Cancer Center โ€” Houston, Texas
  • Virginia Mason Medical Center โ€” Seattle, Washington

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—